BCIC获奖团队Affinity Biopharma融资4亿人民币
Congratulations to Affinity Biopharma for raising 400 milllion CNY ( ~$60 million) , successfully in its series B2 financing round. Affinity Biopharma was awarded with Second Prize award in 2024 Biomedical Pitch Competition organized by Boston Chinese Investment Club （BCIC）and Hong Kong Science and Technology Parks Corporation (HKSTP)
http://www.affinitybiopharma.com/en/newsD-543.html
2024 Biomedical Pitch Competition Final
| First Prize | GV20 Therapeutics |
| Second Prize | Affinity Biopharma |
| Axcynsis Therapeutics | |
| Third Prize | ImmVira Group: A Novel Payload Deliver |
| Rapafusyn Pharmaceuticals | |
| Cure Genetics Inc. | |
| D2M Biotherapeutics | |
| Innovation Award | Leveragen, Inc. |
| f5 Therapeutics Incorporated | |
| Agilis Robotics Limited | |
| Spark Spine | |
| Azura Bio, Inc. | |
| AI-powered Painless Blood Test Device | |
| NeuronOff, Inc. |